Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04271774 · ClinicalTrials.gov registry record

Genome Environment Microbiome and Metabolome in Autism Study

A clinical trial of Autism Spectrum Disorder, sponsored by Massachusetts General Hospital.

Active
Registry status
600
Enrollment target
3
Study locations

NCT04271774 is a study of Autism Spectrum Disorder that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 600 participants, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (351% higher). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04271774, a study of Autism Spectrum Disorder, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
600 participants
Enrollment target
3
Study locations

Study Summary

GEMMA is a multicenter longitudinal observational study that follows children who are genetically at-risk of developing autism for their first three years of life, seeking to identify potential biomarkers predictive of autism development in the blood, stool, urine and saliva. The biomarkers identified in this project will contribute to a better understanding of the pathogenesis of ASD in at-risk children and possible solutions for alleviating and/or preventing ASD and ASD-related symptoms in patients in the future.

Conditions Studied

Autism Spectrum Disorder

Study Locations (3)

Other

  • National University of Ireland Galway - Galway
  • The Azienda Sanitaria Locale Salerno - Salerno

Massachusetts

  • Massachusetts General Hospital for Children - Boston

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2019-07-01
Est. Completion 2025-12-31

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04271774

The ClinicalTrials.gov registry entry for NCT04271774 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (351% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT04271774 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04271774 about?

NCT04271774 is a clinical study titled "Genome Environment Microbiome and Metabolome in Autism Study". GEMMA is a multicenter longitudinal observational study that follows children who are genetically at-risk of developing autism for their first three years of life, seeking to identify potential biomarkers predictive of autism development in the blood, stool, urine and saliva. The biomarkers identifi...

What is the current status of trial NCT04271774?

This trial is currently active not recruiting. The enrollment target is 600 participants. The study started on 2019-07-01. Estimated completion is 2025-12-31.

What conditions does trial NCT04271774 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

Who is sponsoring clinical trial NCT04271774?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04271774 being conducted?

This trial has 3 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism Spectrum Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.